Medicine and Dentistry
Diseases
100%
Infection
84%
Mantoux Test
77%
Chronic Kidney Disease
75%
Clinician
63%
Vitamin D
63%
Mycobacterium Tuberculosis
52%
Prevalence
47%
Randomized Controlled Trial
47%
Human Immunodeficiency Virus
44%
Antimicrobial Therapy
38%
Interferon Gamma Release Assay
37%
Tuberculosis Treatment
36%
Psoriasis
35%
Drug Megadose
35%
Lung Tuberculosis
35%
Necrosis
31%
Antigen Specificity
31%
Cross Sectional Study
31%
Silo-Filler's Disease
31%
Atypical Mycobacterium
31%
Tumor Necrosis
31%
Base
31%
Immunocompromised Patient
31%
Interferon
31%
Infectious Disease
31%
Lung Infection
31%
Serositis
31%
Awareness
31%
Sputum Culture
27%
Culture Conversion
27%
Chemoprophylaxis
24%
Supplementation
23%
Placebo
21%
Hematopoietic Stem Cell Transplantation
21%
Recurrence Risk
21%
Kidney Function
21%
Human Immunodeficiency Virus Infection
18%
Immune Response
17%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Immunosuppressive Drug
15%
Inflammatory Disorder
14%
Colecalciferol
13%
Vitamin D Receptor
13%
Enzyme Linked Immunosorbent Assay
12%
Latent Tuberculosis
12%
Mycobacterium malmoense
10%
Mycobacterium kansasii
10%
Ex Vivo
10%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
87%
Tuberculin
81%
Chronic Kidney Failure
75%
Infection
68%
Vitamin D
63%
Mycobacterium Tuberculosis
52%
HIV
44%
Chemotherapy
41%
Prevalence
39%
Randomized Controlled Trial
39%
Psoriasis
35%
Lung Tuberculosis
35%
Antiinfective Agent
35%
Lung Infection
35%
Tumor Necrosis
31%
Cholecalciferol
31%
Necrosis
31%
Interferon
31%
Atypical Mycobacterium
31%
Cross-Sectional Study
31%
Immunocompromised Patient
31%
Group Trial
31%
Inflammation
31%
Gamma Interferon
24%
Placebo
24%
Recurrence Risk
21%
Immunosuppressive Agent
19%
Human Immunodeficiency Virus Infection
18%
Mycobacterium avium complex
16%
Chemoprophylaxis
16%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Vitamin D Receptor
15%
Inflammatory Disease
14%
Mycobacteria
13%
Enzyme-Linked Immunosorbent Assay
12%
Latent Tuberculosis
12%
Mycobacterium kansasii
10%
Mycobacterium malmoense
10%
25 Hydroxyvitamin D
10%
Tuberculostatic Agent
10%
Retrospective Study
10%
Rifampicin
10%
Chronic Obstructive Lung Disease
10%
Side Effect
10%
Clarithromycin
10%
Adverse Drug Reaction
10%
Ethambutol
10%
Mycobacterium xenopei
10%
Disease Predisposition
10%
Immunology and Microbiology
Mycobacterium Tuberculosis
48%
Human immunodeficiency virus
44%
Mantoux Test
42%
Drug Megadose
42%
Nontuberculous mycobacteria
31%
Inflammation Response
31%
Secretion (Process)
31%
Prevalence
31%
Immunocompromised Patient
31%
Sputum Culture
31%
Sputum
26%
Mycobacterium Avium Complex
22%
Mediator
21%
Hematopoietic Stem Cell Transplantation
21%
Protein Binding
21%
Immunodiagnostics
21%
Immune Response
21%
Mycobacteria
18%
Human Immunodeficiency Virus Infection
18%
Interferon Gamma
16%
Mycobacterium malmoense
15%
Mycobacterium xenopi
15%
TaqI
15%
Mycobacterium kansasii
15%
Metabolite
15%
ELISA
12%
Inflammatory Arthritis
12%
Cytokine Response
10%
Infectious Disease
10%
Immunosuppressive Drug
10%
Adaptive Immune System
10%
Proinflammatory Cytokine
10%
Lymphocytopenia
10%
CCL11
10%
RANTES
10%
Neutrophil Count
10%
Cytokine Storm
10%
Interleukin 4
10%
Blood Level
10%
Interleukin-1
10%
Macrophage
10%
CCL5
10%
Chemokine
10%
Cytokine
10%
CCL2
10%
Lineages
10%
FokI
10%
Species Distribution
9%
Geographic Distribution
6%
Stem Cell Transplant
6%
